Goldman Sachs Amends AEHR Test Systems Stake
Ticker: AEHR · Form: SC 13G/A · Filed: Feb 6, 2024 · CIK: 1040470
| Field | Detail |
|---|---|
| Company | Aehr Test Systems (AEHR) |
| Form Type | SC 13G/A |
| Filed Date | Feb 6, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, 13G, portfolio-change
TL;DR
**Goldman Sachs just tweaked its AEHR holdings, watch for market reaction.**
AI Summary
Goldman Sachs Group Inc. filed an amended SC 13G/A on February 6, 2024, indicating a change in their beneficial ownership of AEHR Test Systems' Common Stock as of December 29, 2023. This filing, an amendment to a previous disclosure, signals that Goldman Sachs, a major financial institution, has adjusted its stake in AEHR. For investors, this matters because significant changes in holdings by large institutional investors like Goldman Sachs can sometimes influence market sentiment and stock price, suggesting either a re-evaluation of the company's prospects or a portfolio rebalancing.
Why It Matters
This filing shows a major institutional investor, Goldman Sachs, has updated its position in AEHR Test Systems, which can signal shifts in institutional confidence or strategy.
Risk Assessment
Risk Level: low — This filing is a routine update from a large institutional investor and does not inherently indicate high risk for the company.
Analyst Insight
An investor should note that a major institution like Goldman Sachs is adjusting its position, but without knowing the specifics of the change (increase or decrease in shares), it's best to monitor future filings or news for more context before making investment decisions.
Key Players & Entities
- Goldman Sachs Group Inc. (company) — the entity filing the SC 13G/A, reporting beneficial ownership in AEHR Test Systems
- AEHR Test Systems (company) — the issuer whose Common Stock is being reported on
- December 29, 2023 (date) — the date of the event which required the filing of this statement
- $0.01 (dollar_amount) — the par value per share of AEHR Test Systems' Common Stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)*' sections.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is Goldman Sachs Group Inc., as indicated in the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GOLDMAN SACHS GROUP INC' section.
What is the subject company of this filing?
The subject company, or issuer, is AEHR Test Systems, as stated in the 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AEHR TEST SYSTEMS' section and 'AEHR TEST SYSTEMS (Name of Issuer)'.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of AEHR Test Systems is 00760J108, as listed under 'CUSIP Number' on the cover page and 'CUSIP No. 00760J108' on Page 1 of 11.
When was the event that triggered this filing?
The date of the event which required the filing of this statement was December 29, 2023, as specified in the 'Date of Event Which Requires Filing of this Statement' section.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 6, 2024 regarding AEHR TEST SYSTEMS (AEHR).